Meril Life Sciences unveils MyClip, a groundbreaking Transcatheter Edge-to-Edge Repair system for treating severe Mitral ...

The launch event concluded with a call to build a sustainable M-TEER ecosystem in India, focused on accessibility, clinical ...

For the estimated 1.6 million Americans diagnosed with symptomatic tricuspid valve regurgitation each year, a significant advancement in treatment is now available on Long Island. With the launch of ...

Objective This study aims to evaluate the role of antiphospholipid antibodies (aPLs) in patients with SLE with heart valve ...

The transcatheter heart valve replacement (TAVR) market is reported to reach a valuation of at USD 8.18 billion in 2025 to USD 32.82 billion by 2035. Demand for TAVR is expected to rise at a CAGR of ...

Stony Brook Heart Institute launches new program, offering minimally invasive therapies for symptomatic tricuspid valve ...

The TEER procedure is highly recommended for patients who are considered high surgical risk due to pre-existing issues like ...

Mitral regurgitation describes when the mitral valve allows blood to flow back into a person's ... A review from 2018 does not recommend people with moderate or severe mitral regurgitation to fly.

While previous trials have led to questions surrounding the potential benefits of valve interventions in mitral or tricuspid regurgitation, a pair of trials presented recently demonstrate their ...

Whether transcatheter mitral-valve repair improves outcomes in patients with heart failure and functional mitral regurgitation is uncertain.We conducted a randomized, controlled trial involving pat ...

Women vs men with indications (n=330) were older (79 vs 76 years; P =.01) with higher Society of Thoracic Surgeons risk scores for mitral valve repair (2.5% vs 1.4%; P =.003).